Knowledge of clinical pathway for children undergoing congenital cardiac surgeries

Insights

Clinical pathways improve care for children with congenital heart disease. This study found that using clinical pathways enhanced nurses' knowledge and provided timely, cost-effective, high-quality care.

Area of Science:

  • Pediatric Cardiology
  • Nursing Education
  • Healthcare Management

Background:

  • Congenital heart disease requires specialized care.
  • Clinical pathways are increasingly used to standardize patient management.
  • Effective documentation and care delivery are crucial for pediatric cardiac patients.

Purpose of the Study:

  • To assess the impact of clinical pathways on nursing knowledge regarding congenital heart disease care.
  • To evaluate the effectiveness of clinical pathways in delivering timely and cost-effective care.
  • To determine if clinical pathways enhance the quality of care for children with congenital heart disease.

Main Methods:

  • A quasi-experimental pre-test post-test design was employed.
  • The study included 40 nurses and 50 children with congenital heart disease, divided into experimental and control groups.
  • Nursing knowledge was assessed using a structured questionnaire, with demographic data collected via proformas.

Main Results:

  • Nurses in the experimental group demonstrated increased knowledge of clinical pathways.
  • The implementation of clinical pathways was associated with improved care delivery.
  • The study indicated that clinical pathways are a viable tool for enhancing care quality.

Conclusions:

  • Clinical pathways are effective in improving nursing knowledge and patient care for congenital heart disease.
  • This modality offers a timely and cost-effective approach to managing pediatric cardiac conditions.
  • The findings support the integration of clinical pathways into standard practice for congenital heart disease management.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.0K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
442
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
805
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
2.1K